$HIMS fwd P/E of 34x. Hold my beer :)

$TSLA Robotaxi thesis will slowly start to crumble

Hims & Hers Health sees its shares fall 9.4% in premarket trading following a negative court ruling related to the weight-loss drug shortage. The Texas Northern Court ruled in favor of the FDA and against the Outsourcing Facilities Association (OFA) regarding the regulator's

UBER Q4'24: For Q1 2025, we anticipate: • Gross Bookings of growth of 17% to 21% YoY on a constant currency basis. • This translates to reported Gross Bookings of $42.0 billion to $43.5 billion as our outlook assumes a roughly 5.5 percentage point currency headwind to total

As a founder-led company, we have one rare advantage that most companies do not, extreme patients." This is what andrewdudum said during $HIMS Q4'24 earnings call. It was before the stock lost 50% in price. Due to the drawdown, I decided to read the Q4'24 earnings call again

$DUOL will explode thanks to AI: 1) The content will grow exponentially 2) The costs will go down significantly "The AI investments were – they’re basically coming in – and expenses. They’re basically coming in two parts. We’re definitely investing in AI to automate things

JUST IN: $HIMS has officially joined the S&P MidCap 400 Index. ✅

S&P 500 coming next year :)

$HIMS is advertising a petition to congress to approve their GLP-1’s

Elon, please send me within 48 hours what you've done for your company. $TSLA is 50% from ATH and is still traded at ridiculous multiples. In the meantime, $UBER has partnered with several AV companies. European Tesla sales are plummeting. Elon Musk will be also considered as

🚨 $HIMS DROPS NEW 2-IN-1 SEX + TESTOSTERONE AD ON INSTAGRAM

$TSLA another 10% drop today :)

$AMD doesn't appear to be a dead company in the end.

Grab seeks up to $2B loan for possible GoTo takeover Grab is reportedly seeking a bridge loan of up to $2 billion to finance a potential acquisition of GoTo, an Indonesian tech company. According to Bloomberg News, the loan discussions with banks are in preliminary stages and

$HIMS is tremendously undervalued

BREAKING: $HIMS to sell Eli Lilly's $LLY Zepbound.

IMPORTANT: If you visit $HIMS' website, you'll see that they're not just offering Zepbound — they're also providing other branded GLP-1s, including Ozempic and Wegovy. This likely indicates that $HIMS is partnering with $NVO as well. 👀 Great news IMO.

$AMD: +19% $HIMS: +111% $UBER: +60% $MELI: +42% $ASML: +2% I guess I'm outperforming the index this year...

Goldman Sachs begins coverage of Advanced Micro Devices $AMD with a Neutral rating and sets a price target of $140. Reasoning: AMD has shown strong execution, gaining market share in X86 Server and PC CPUs, with 21.71% revenue growth over the past year, reaching $27.75 billion.

Son: Dad, why is my sister’s name Rose? Dad: Because your mother loves roses, son. Son: Oh, okay. Thanks, Dad! Dad: You’re welcome, Arkady Volozh $NBIS.